222 related articles for article (PubMed ID: 34783962)
1. The role of endoglin and its soluble form in pathogenesis of preeclampsia.
Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Vavoulidis E; Gullo G; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
Mol Cell Biochem; 2022 Feb; 477(2):479-491. PubMed ID: 34783962
[TBL] [Abstract][Full Text] [Related]
2. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
3. Membrane and soluble forms of endoglin in preeclampsia.
Oujo B; Perez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Curr Mol Med; 2013 Sep; 13(8):1345-57. PubMed ID: 23826920
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.
Pérez-Roque L; Núñez-Gómez E; Rodríguez-Barbero A; Bernabéu C; López-Novoa JM; Pericacho M
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375253
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.
Onda K; Tong S; Beard S; Binder N; Muto M; Senadheera SN; Parry L; Dilworth M; Renshall L; Brownfoot F; Hastie R; Tuohey L; Palmer K; Hirano T; Ikawa M; Kaitu'u-Lino T; Hannan NJ
Hypertension; 2017 Mar; 69(3):457-468. PubMed ID: 28115513
[TBL] [Abstract][Full Text] [Related]
6. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
Liu L; Wang R; Xu R; Chu Y; Gu W
Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
[TBL] [Abstract][Full Text] [Related]
7. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
8. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
9. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic Imbalance as a Contributor of Preeclampsia.
Dymara-Konopka W; Laskowska M; Błażewicz A
Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
[TBL] [Abstract][Full Text] [Related]
14. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
15. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.
Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S
Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769
[TBL] [Abstract][Full Text] [Related]
16. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
Boulanger H; Flamant M
Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
[TBL] [Abstract][Full Text] [Related]
17. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
18. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
[TBL] [Abstract][Full Text] [Related]
19. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.
Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S
PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148
[TBL] [Abstract][Full Text] [Related]
20. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
